BindingDB logo
myBDB logout
Compile Data Set for Download or QSAR

Found 53 hits with Last Name = 'gesell' and Initial = 'j'   
Target/Host
(Institution)
LigandTarget/Host
Links
Ligand
Links
Trg + Lig
Links
Ki
nM
ΔG°
kJ/mole
IC50
nM
Kd
nM
EC50/IC50
nM
koff
s-1
kon
M-1s-1
pHTemp
°C
E3 ubiquitin-protein ligase Mdm2


(Homo sapiens (Human))
BDBM31225
PNG
(2-phenoxybenzoyltryptophan derivative, R5C3)
Show SMILES Cc1ccc2n(cc(C[C@H](NC(=O)c3ccccc3Oc3ccccc3)C(O)=O)c2c1)C(=O)OCc1ccccc1 |r|
Show InChI InChI=1S/C33H28N2O6/c1-22-16-17-29-27(18-22)24(20-35(29)33(39)40-21-23-10-4-2-5-11-23)19-28(32(37)38)34-31(36)26-14-8-9-15-30(26)41-25-12-6-3-7-13-25/h2-18,20,28H,19,21H2,1H3,(H,34,36)(H,37,38)/t28-/m0/s1
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
Purchase

PC cid
PC sid
UniChem

Similars

Article
PubMed
100 -39.7n/an/an/an/an/a7.423



Schering-Plough Research Institute



Assay Description
Ki values were determined from a competition experiment in which serial dilutions of inhibitor were added to compete against a fixed concentration (1...


Anal Biochem 331: 138-46 (2004)


Article DOI: 10.1016/j.ab.2004.03.009
BindingDB Entry DOI: 10.7270/Q2VX0DVV
More data for this
Ligand-Target Pair
E3 ubiquitin-protein ligase Mdm2


(Homo sapiens (Human))
BDBM31224
PNG
(2-phenoxybenzoyltryptophan derivative, R5C2)
Show SMILES Cc1ccc2n(cc(C[C@H](NC(=O)c3ccccc3Oc3ccccc3)C(O)=O)c2c1)C(=O)CCC1CCCC1 |r|
Show InChI InChI=1S/C33H34N2O5/c1-22-15-17-29-27(19-22)24(21-35(29)31(36)18-16-23-9-5-6-10-23)20-28(33(38)39)34-32(37)26-13-7-8-14-30(26)40-25-11-3-2-4-12-25/h2-4,7-8,11-15,17,19,21,23,28H,5-6,9-10,16,18,20H2,1H3,(H,34,37)(H,38,39)/t28-/m0/s1
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem

Similars

Article
PubMed
200 -38.0n/an/an/an/an/a7.423



Schering-Plough Research Institute



Assay Description
Ki values were determined from a competition experiment in which serial dilutions of inhibitor were added to compete against a fixed concentration (1...


Anal Biochem 331: 138-46 (2004)


Article DOI: 10.1016/j.ab.2004.03.009
BindingDB Entry DOI: 10.7270/Q2VX0DVV
More data for this
Ligand-Target Pair
E3 ubiquitin-protein ligase Mdm2


(Homo sapiens (Human))
BDBM31216
PNG
(2-phenoxybenzoyltryptophan derivative, R3C2)
Show SMILES OC(=O)[C@H](Cc1cn(C(=O)CCC2CCCC2)c2cc(F)ccc12)NC(=O)c1ccccc1Oc1ccccc1 |r|
Show InChI InChI=1S/C32H31FN2O5/c33-23-15-16-25-22(20-35(28(25)19-23)30(36)17-14-21-8-4-5-9-21)18-27(32(38)39)34-31(37)26-12-6-7-13-29(26)40-24-10-2-1-3-11-24/h1-3,6-7,10-13,15-16,19-21,27H,4-5,8-9,14,17-18H2,(H,34,37)(H,38,39)/t27-/m0/s1
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem

Similars

Article
PubMed
400 -36.3n/an/an/an/an/a7.423



Schering-Plough Research Institute



Assay Description
Ki values were determined from a competition experiment in which serial dilutions of inhibitor were added to compete against a fixed concentration (1...


Anal Biochem 331: 138-46 (2004)


Article DOI: 10.1016/j.ab.2004.03.009
BindingDB Entry DOI: 10.7270/Q2VX0DVV
More data for this
Ligand-Target Pair
E3 ubiquitin-protein ligase Mdm2


(Homo sapiens (Human))
BDBM31209
PNG
(2-phenoxybenzoyltryptophan derivative, R1C3)
Show SMILES OC(=O)[C@H](Cc1cn(C(=O)OCc2ccccc2)c2cc(Br)ccc12)NC(=O)c1ccccc1Oc1ccccc1 |r|
Show InChI InChI=1S/C32H25BrN2O6/c33-23-15-16-25-22(19-35(28(25)18-23)32(39)40-20-21-9-3-1-4-10-21)17-27(31(37)38)34-30(36)26-13-7-8-14-29(26)41-24-11-5-2-6-12-24/h1-16,18-19,27H,17,20H2,(H,34,36)(H,37,38)/t27-/m0/s1
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem

Similars

Article
PubMed
500 -35.7n/an/an/an/an/a7.423



Schering-Plough Research Institute



Assay Description
Ki values were determined from a competition experiment in which serial dilutions of inhibitor were added to compete against a fixed concentration (1...


Anal Biochem 331: 138-46 (2004)


Article DOI: 10.1016/j.ab.2004.03.009
BindingDB Entry DOI: 10.7270/Q2VX0DVV
More data for this
Ligand-Target Pair
E3 ubiquitin-protein ligase Mdm2


(Homo sapiens (Human))
BDBM31210
PNG
(2-phenoxybenzoyltryptophan derivative, R1C4)
Show SMILES OC(=O)[C@H](Cc1cn(Cc2ccc(OCc3ccccc3)cc2)c2cc(Br)ccc12)NC(=O)c1ccccc1Oc1ccccc1 |r|
Show InChI InChI=1S/C38H31BrN2O5/c39-29-17-20-32-28(21-34(38(43)44)40-37(42)33-13-7-8-14-36(33)46-31-11-5-2-6-12-31)24-41(35(32)22-29)23-26-15-18-30(19-16-26)45-25-27-9-3-1-4-10-27/h1-20,22,24,34H,21,23,25H2,(H,40,42)(H,43,44)/t34-/m0/s1
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem

Similars

Article
PubMed
600 -35.3n/an/an/an/an/a7.423



Schering-Plough Research Institute



Assay Description
Ki values were determined from a competition experiment in which serial dilutions of inhibitor were added to compete against a fixed concentration (1...


Anal Biochem 331: 138-46 (2004)


Article DOI: 10.1016/j.ab.2004.03.009
BindingDB Entry DOI: 10.7270/Q2VX0DVV
More data for this
Ligand-Target Pair
E3 ubiquitin-protein ligase Mdm2


(Homo sapiens (Human))
BDBM31220
PNG
(2-phenoxybenzoyltryptophan derivative, R4C2)
Show SMILES OC(=O)[C@H](Cc1cn(C(=O)CCC2CCCC2)c2ccc(cc12)C#N)NC(=O)c1ccccc1Oc1ccccc1 |r|
Show InChI InChI=1S/C33H31N3O5/c34-20-23-14-16-29-27(18-23)24(21-36(29)31(37)17-15-22-8-4-5-9-22)19-28(33(39)40)35-32(38)26-12-6-7-13-30(26)41-25-10-2-1-3-11-25/h1-3,6-7,10-14,16,18,21-22,28H,4-5,8-9,15,17,19H2,(H,35,38)(H,39,40)/t28-/m0/s1
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem

Similars

Article
PubMed
600 -35.3n/an/an/an/an/a7.423



Schering-Plough Research Institute



Assay Description
Ki values were determined from a competition experiment in which serial dilutions of inhibitor were added to compete against a fixed concentration (1...


Anal Biochem 331: 138-46 (2004)


Article DOI: 10.1016/j.ab.2004.03.009
BindingDB Entry DOI: 10.7270/Q2VX0DVV
More data for this
Ligand-Target Pair
E3 ubiquitin-protein ligase Mdm2


(Homo sapiens (Human))
BDBM31226
PNG
(2-phenoxybenzoyltryptophan derivative, R5C4)
Show SMILES Cc1ccc2n(Cc3ccc(OCc4ccccc4)cc3)cc(C[C@H](NC(=O)c3ccccc3Oc3ccccc3)C(O)=O)c2c1 |r|
Show InChI InChI=1S/C39H34N2O5/c1-27-16-21-36-34(22-27)30(25-41(36)24-28-17-19-31(20-18-28)45-26-29-10-4-2-5-11-29)23-35(39(43)44)40-38(42)33-14-8-9-15-37(33)46-32-12-6-3-7-13-32/h2-22,25,35H,23-24,26H2,1H3,(H,40,42)(H,43,44)/t35-/m0/s1
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem

Similars

Article
PubMed
600 -35.3n/an/an/an/an/a7.423



Schering-Plough Research Institute



Assay Description
Ki values were determined from a competition experiment in which serial dilutions of inhibitor were added to compete against a fixed concentration (1...


Anal Biochem 331: 138-46 (2004)


Article DOI: 10.1016/j.ab.2004.03.009
BindingDB Entry DOI: 10.7270/Q2VX0DVV
More data for this
Ligand-Target Pair
E3 ubiquitin-protein ligase Mdm2


(Homo sapiens (Human))
BDBM31213
PNG
(2-phenoxybenzoyltryptophan derivative, R2C3)
Show SMILES OC(=O)[C@H](Cc1cn(C(=O)OCc2ccccc2)c2cc(Cl)ccc12)NC(=O)c1ccccc1Oc1ccccc1 |r|
Show InChI InChI=1S/C32H25ClN2O6/c33-23-15-16-25-22(19-35(28(25)18-23)32(39)40-20-21-9-3-1-4-10-21)17-27(31(37)38)34-30(36)26-13-7-8-14-29(26)41-24-11-5-2-6-12-24/h1-16,18-19,27H,17,20H2,(H,34,36)(H,37,38)/t27-/m0/s1
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem

Similars

Article
PubMed
600 -35.3n/an/an/an/an/a7.423



Schering-Plough Research Institute



Assay Description
Ki values were determined from a competition experiment in which serial dilutions of inhibitor were added to compete against a fixed concentration (1...


Anal Biochem 331: 138-46 (2004)


Article DOI: 10.1016/j.ab.2004.03.009
BindingDB Entry DOI: 10.7270/Q2VX0DVV
More data for this
Ligand-Target Pair
E3 ubiquitin-protein ligase Mdm2


(Homo sapiens (Human))
BDBM31221
PNG
(2-phenoxybenzoyltryptophan derivative, R4C3)
Show SMILES OC(=O)[C@H](Cc1cn(C(=O)OCc2ccccc2)c2ccc(cc12)C#N)NC(=O)c1ccccc1Oc1ccccc1 |r|
Show InChI InChI=1S/C33H25N3O6/c34-19-23-15-16-29-27(17-23)24(20-36(29)33(40)41-21-22-9-3-1-4-10-22)18-28(32(38)39)35-31(37)26-13-7-8-14-30(26)42-25-11-5-2-6-12-25/h1-17,20,28H,18,21H2,(H,35,37)(H,38,39)/t28-/m0/s1
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem

Similars

Article
PubMed
600 -35.3n/an/an/an/an/a7.423



Schering-Plough Research Institute



Assay Description
Ki values were determined from a competition experiment in which serial dilutions of inhibitor were added to compete against a fixed concentration (1...


Anal Biochem 331: 138-46 (2004)


Article DOI: 10.1016/j.ab.2004.03.009
BindingDB Entry DOI: 10.7270/Q2VX0DVV
More data for this
Ligand-Target Pair
E3 ubiquitin-protein ligase Mdm2


(Homo sapiens (Human))
BDBM31217
PNG
(2-phenoxybenzoyltryptophan derivative, R3C3)
Show SMILES OC(=O)[C@H](Cc1cn(C(=O)OCc2ccccc2)c2cc(F)ccc12)NC(=O)c1ccccc1Oc1ccccc1 |r|
Show InChI InChI=1S/C32H25FN2O6/c33-23-15-16-25-22(19-35(28(25)18-23)32(39)40-20-21-9-3-1-4-10-21)17-27(31(37)38)34-30(36)26-13-7-8-14-29(26)41-24-11-5-2-6-12-24/h1-16,18-19,27H,17,20H2,(H,34,36)(H,37,38)/t27-/m0/s1
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem

Similars

Article
PubMed
800 -34.6n/an/an/an/an/a7.423



Schering-Plough Research Institute



Assay Description
Ki values were determined from a competition experiment in which serial dilutions of inhibitor were added to compete against a fixed concentration (1...


Anal Biochem 331: 138-46 (2004)


Article DOI: 10.1016/j.ab.2004.03.009
BindingDB Entry DOI: 10.7270/Q2VX0DVV
More data for this
Ligand-Target Pair
E3 ubiquitin-protein ligase Mdm2


(Homo sapiens (Human))
BDBM31212
PNG
(2-phenoxybenzoyltryptophan derivative, R2C2)
Show SMILES OC(=O)[C@H](Cc1cn(C(=O)CCC2CCCC2)c2cc(Cl)ccc12)NC(=O)c1ccccc1Oc1ccccc1 |r|
Show InChI InChI=1S/C32H31ClN2O5/c33-23-15-16-25-22(20-35(28(25)19-23)30(36)17-14-21-8-4-5-9-21)18-27(32(38)39)34-31(37)26-12-6-7-13-29(26)40-24-10-2-1-3-11-24/h1-3,6-7,10-13,15-16,19-21,27H,4-5,8-9,14,17-18H2,(H,34,37)(H,38,39)/t27-/m0/s1
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem

Similars

Article
PubMed
800 -34.6n/an/an/an/an/a7.423



Schering-Plough Research Institute



Assay Description
Ki values were determined from a competition experiment in which serial dilutions of inhibitor were added to compete against a fixed concentration (1...


Anal Biochem 331: 138-46 (2004)


Article DOI: 10.1016/j.ab.2004.03.009
BindingDB Entry DOI: 10.7270/Q2VX0DVV
More data for this
Ligand-Target Pair
E3 ubiquitin-protein ligase Mdm2


(Homo sapiens (Human))
BDBM31208
PNG
(2-phenoxybenzoyltryptophan derivative, R1C2)
Show SMILES OC(=O)[C@H](Cc1cn(C(=O)CCC2CCCC2)c2cc(Br)ccc12)NC(=O)c1ccccc1Oc1ccccc1 |r|
Show InChI InChI=1S/C32H31BrN2O5/c33-23-15-16-25-22(20-35(28(25)19-23)30(36)17-14-21-8-4-5-9-21)18-27(32(38)39)34-31(37)26-12-6-7-13-29(26)40-24-10-2-1-3-11-24/h1-3,6-7,10-13,15-16,19-21,27H,4-5,8-9,14,17-18H2,(H,34,37)(H,38,39)/t27-/m0/s1
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem

Similars

Article
PubMed
800 -34.6n/an/an/an/an/a7.423



Schering-Plough Research Institute



Assay Description
Ki values were determined from a competition experiment in which serial dilutions of inhibitor were added to compete against a fixed concentration (1...


Anal Biochem 331: 138-46 (2004)


Article DOI: 10.1016/j.ab.2004.03.009
BindingDB Entry DOI: 10.7270/Q2VX0DVV
More data for this
Ligand-Target Pair
E3 ubiquitin-protein ligase Mdm2


(Homo sapiens (Human))
BDBM31214
PNG
(2-phenoxybenzoyltryptophan derivative, R2C4)
Show SMILES OC(=O)[C@H](Cc1cn(Cc2ccc(OCc3ccccc3)cc2)c2cc(Cl)ccc12)NC(=O)c1ccccc1Oc1ccccc1 |r|
Show InChI InChI=1S/C38H31ClN2O5/c39-29-17-20-32-28(21-34(38(43)44)40-37(42)33-13-7-8-14-36(33)46-31-11-5-2-6-12-31)24-41(35(32)22-29)23-26-15-18-30(19-16-26)45-25-27-9-3-1-4-10-27/h1-20,22,24,34H,21,23,25H2,(H,40,42)(H,43,44)/t34-/m0/s1
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem

Similars

Article
PubMed
1.00E+3 -34.0n/an/an/an/an/a7.423



Schering-Plough Research Institute



Assay Description
Ki values were determined from a competition experiment in which serial dilutions of inhibitor were added to compete against a fixed concentration (1...


Anal Biochem 331: 138-46 (2004)


Article DOI: 10.1016/j.ab.2004.03.009
BindingDB Entry DOI: 10.7270/Q2VX0DVV
More data for this
Ligand-Target Pair
E3 ubiquitin-protein ligase Mdm2


(Homo sapiens (Human))
BDBM31222
PNG
(2-phenoxybenzoyltryptophan derivative, R4C4)
Show SMILES OC(=O)[C@H](Cc1cn(Cc2ccc(OCc3ccccc3)cc2)c2ccc(cc12)C#N)NC(=O)c1ccccc1Oc1ccccc1 |r|
Show InChI InChI=1S/C39H31N3O5/c40-23-29-17-20-36-34(21-29)30(25-42(36)24-27-15-18-31(19-16-27)46-26-28-9-3-1-4-10-28)22-35(39(44)45)41-38(43)33-13-7-8-14-37(33)47-32-11-5-2-6-12-32/h1-21,25,35H,22,24,26H2,(H,41,43)(H,44,45)/t35-/m0/s1
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem

Similars

Article
PubMed
1.00E+3 -34.0n/an/an/an/an/a7.423



Schering-Plough Research Institute



Assay Description
Ki values were determined from a competition experiment in which serial dilutions of inhibitor were added to compete against a fixed concentration (1...


Anal Biochem 331: 138-46 (2004)


Article DOI: 10.1016/j.ab.2004.03.009
BindingDB Entry DOI: 10.7270/Q2VX0DVV
More data for this
Ligand-Target Pair
E3 ubiquitin-protein ligase Mdm2


(Homo sapiens (Human))
BDBM31218
PNG
(2-phenoxybenzoyltryptophan derivative, R3C4)
Show SMILES OC(=O)[C@H](Cc1cn(Cc2ccc(OCc3ccccc3)cc2)c2cc(F)ccc12)NC(=O)c1ccccc1Oc1ccccc1 |r|
Show InChI InChI=1S/C38H31FN2O5/c39-29-17-20-32-28(21-34(38(43)44)40-37(42)33-13-7-8-14-36(33)46-31-11-5-2-6-12-31)24-41(35(32)22-29)23-26-15-18-30(19-16-26)45-25-27-9-3-1-4-10-27/h1-20,22,24,34H,21,23,25H2,(H,40,42)(H,43,44)/t34-/m0/s1
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem

Similars

Article
PubMed
2.00E+3 -32.3n/an/an/an/an/a7.423



Schering-Plough Research Institute



Assay Description
Ki values were determined from a competition experiment in which serial dilutions of inhibitor were added to compete against a fixed concentration (1...


Anal Biochem 331: 138-46 (2004)


Article DOI: 10.1016/j.ab.2004.03.009
BindingDB Entry DOI: 10.7270/Q2VX0DVV
More data for this
Ligand-Target Pair
E3 ubiquitin-protein ligase Mdm2


(Homo sapiens (Human))
BDBM31207
PNG
(2-phenoxybenzoyltryptophan derivative, R1C1)
Show SMILES OC(=O)[C@H](Cc1c[nH]c2cc(Br)ccc12)NC(=O)c1ccccc1Oc1ccccc1 |r|
Show InChI InChI=1S/C24H19BrN2O4/c25-16-10-11-18-15(14-26-20(18)13-16)12-21(24(29)30)27-23(28)19-8-4-5-9-22(19)31-17-6-2-1-3-7-17/h1-11,13-14,21,26H,12H2,(H,27,28)(H,29,30)/t21-/m0/s1
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem

Similars

Article
PubMed
3.00E+3 -31.3n/an/an/an/an/a7.423



Schering-Plough Research Institute



Assay Description
Ki values were determined from a competition experiment in which serial dilutions of inhibitor were added to compete against a fixed concentration (1...


Anal Biochem 331: 138-46 (2004)


Article DOI: 10.1016/j.ab.2004.03.009
BindingDB Entry DOI: 10.7270/Q2VX0DVV
More data for this
Ligand-Target Pair
E3 ubiquitin-protein ligase Mdm2


(Homo sapiens (Human))
BDBM31211
PNG
(2-phenoxybenzoyltryptophan derivative, R2C1)
Show SMILES OC(=O)[C@H](Cc1c[nH]c2cc(Cl)ccc12)NC(=O)c1ccccc1Oc1ccccc1 |r|
Show InChI InChI=1S/C24H19ClN2O4/c25-16-10-11-18-15(14-26-20(18)13-16)12-21(24(29)30)27-23(28)19-8-4-5-9-22(19)31-17-6-2-1-3-7-17/h1-11,13-14,21,26H,12H2,(H,27,28)(H,29,30)/t21-/m0/s1
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem

Similars

Article
PubMed
6.00E+3 -29.6n/an/an/an/an/a7.423



Schering-Plough Research Institute



Assay Description
Ki values were determined from a competition experiment in which serial dilutions of inhibitor were added to compete against a fixed concentration (1...


Anal Biochem 331: 138-46 (2004)


Article DOI: 10.1016/j.ab.2004.03.009
BindingDB Entry DOI: 10.7270/Q2VX0DVV
More data for this
Ligand-Target Pair
E3 ubiquitin-protein ligase Mdm2


(Homo sapiens (Human))
BDBM31219
PNG
(2-phenoxybenzoyltryptophan derivative, R4C1)
Show SMILES OC(=O)[C@H](Cc1c[nH]c2ccc(cc12)C#N)NC(=O)c1ccccc1Oc1ccccc1 |r|
Show InChI InChI=1S/C25H19N3O4/c26-14-16-10-11-21-20(12-16)17(15-27-21)13-22(25(30)31)28-24(29)19-8-4-5-9-23(19)32-18-6-2-1-3-7-18/h1-12,15,22,27H,13H2,(H,28,29)(H,30,31)/t22-/m0/s1
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem

Similars

Article
PubMed
1.00E+4 -28.3n/an/an/an/an/a7.423



Schering-Plough Research Institute



Assay Description
Ki values were determined from a competition experiment in which serial dilutions of inhibitor were added to compete against a fixed concentration (1...


Anal Biochem 331: 138-46 (2004)


Article DOI: 10.1016/j.ab.2004.03.009
BindingDB Entry DOI: 10.7270/Q2VX0DVV
More data for this
Ligand-Target Pair
E3 ubiquitin-protein ligase Mdm2


(Homo sapiens (Human))
BDBM31223
PNG
(2-phenoxybenzoyltryptophan derivative, R5C1)
Show SMILES Cc1ccc2[nH]cc(C[C@H](NC(=O)c3ccccc3Oc3ccccc3)C(O)=O)c2c1 |r|
Show InChI InChI=1S/C25H22N2O4/c1-16-11-12-21-20(13-16)17(15-26-21)14-22(25(29)30)27-24(28)19-9-5-6-10-23(19)31-18-7-3-2-4-8-18/h2-13,15,22,26H,14H2,1H3,(H,27,28)(H,29,30)/t22-/m0/s1
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem

Similars

Article
PubMed
1.00E+4 -28.3n/an/an/an/an/a7.423



Schering-Plough Research Institute



Assay Description
Ki values were determined from a competition experiment in which serial dilutions of inhibitor were added to compete against a fixed concentration (1...


Anal Biochem 331: 138-46 (2004)


Article DOI: 10.1016/j.ab.2004.03.009
BindingDB Entry DOI: 10.7270/Q2VX0DVV
More data for this
Ligand-Target Pair
E3 ubiquitin-protein ligase Mdm2


(Homo sapiens (Human))
BDBM31215
PNG
(2-phenoxybenzoyltryptophan derivative, R3C1)
Show SMILES OC(=O)[C@H](Cc1c[nH]c2cc(F)ccc12)NC(=O)c1ccccc1Oc1ccccc1 |r|
Show InChI InChI=1S/C24H19FN2O4/c25-16-10-11-18-15(14-26-20(18)13-16)12-21(24(29)30)27-23(28)19-8-4-5-9-22(19)31-17-6-2-1-3-7-17/h1-11,13-14,21,26H,12H2,(H,27,28)(H,29,30)/t21-/m0/s1
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem

Similars

Article
PubMed
2.00E+4 -26.6n/an/an/an/an/a7.423



Schering-Plough Research Institute



Assay Description
Ki values were determined from a competition experiment in which serial dilutions of inhibitor were added to compete against a fixed concentration (1...


Anal Biochem 331: 138-46 (2004)


Article DOI: 10.1016/j.ab.2004.03.009
BindingDB Entry DOI: 10.7270/Q2VX0DVV
More data for this
Ligand-Target Pair
Protease


(Human immunodeficiency virus 1 (HIV-1))
BDBM13934
PNG
(Atazanavir | BMS 232632 | CGP 73547 | CHEMBL1163 |...)
Show SMILES COC(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)[C@@H](O)CN(Cc1ccc(cc1)-c1ccccn1)NC(=O)[C@@H](NC(=O)OC)C(C)(C)C)C(C)(C)C |r|
Show InChI InChI=1S/C38H52N6O7/c1-37(2,3)31(41-35(48)50-7)33(46)40-29(22-25-14-10-9-11-15-25)30(45)24-44(43-34(47)32(38(4,5)6)42-36(49)51-8)23-26-17-19-27(20-18-26)28-16-12-13-21-39-28/h9-21,29-32,45H,22-24H2,1-8H3,(H,40,46)(H,41,48)(H,42,49)(H,43,47)/t29-,30-,31+,32+/m0/s1
PDB

UniProtKB/TrEMBL

B.MOAD
GoogleScholar
AffyNet 
Purchase

CHEMBL
DrugBank
MCE
MMDB
PC cid
PC sid
PDB
UniChem

Patents


Similars

PDB
Article
PubMed
n/an/a 0.0400n/an/an/an/an/an/a



Merck Research Laboratories

Curated by ChEMBL


Assay Description
Inhibition of wild-type HIV1 protease expressed in Escherichia coli assessed as reduction in product formation preincubated for 30 mins followed by a...


ACS Med Chem Lett 7: 702-7 (2016)


Article DOI: 10.1021/acsmedchemlett.6b00135
BindingDB Entry DOI: 10.7270/Q28W3G74
More data for this
Ligand-Target Pair
3D
3D Structure (crystal)
Protease


(Human immunodeficiency virus 1 (HIV-1))
BDBM50190623
PNG
(CHEMBL3828743)
Show SMILES N[C@@H]([C@@H](c1ccc(Cl)cc1)c1cc(F)cc(F)c1)C(=O)Nc1cncc(F)c1CC[C@@H]1CN[C@H](COC(=O)NCC(F)(F)F)CO1 |r|
Show InChI InChI=1S/C30H30ClF6N5O4/c31-18-3-1-16(2-4-18)26(17-7-19(32)9-20(33)8-17)27(38)28(43)42-25-12-39-11-24(34)23(25)6-5-22-10-40-21(13-45-22)14-46-29(44)41-15-30(35,36)37/h1-4,7-9,11-12,21-22,26-27,40H,5-6,10,13-15,38H2,(H,41,44)(H,42,43)/t21-,22+,26-,27-/m0/s1
PDB

UniProtKB/TrEMBL

B.MOAD
GoogleScholar
AffyNet 
Purchase

CHEMBL
PC cid
PC sid
PDB
UniChem

Similars

Article
PubMed
n/an/a 0.800n/an/an/an/an/an/a



Merck Research Laboratories

Curated by ChEMBL


Assay Description
Inhibition of wild-type HIV1 protease expressed in Escherichia coli assessed as reduction in product formation preincubated for 30 mins followed by a...


ACS Med Chem Lett 7: 702-7 (2016)


Article DOI: 10.1021/acsmedchemlett.6b00135
BindingDB Entry DOI: 10.7270/Q28W3G74
More data for this
Ligand-Target Pair
Protease


(Human immunodeficiency virus 1 (HIV-1))
BDBM50190624
PNG
(CHEMBL3828417)
Show SMILES N[C@@H]([C@@H](c1ccc(F)cc1)c1cc(F)cc(F)c1)C(=O)Nc1cncc(F)c1CC[C@@H]1CN[C@H](COC(=O)NCC(F)(F)F)CO1 |r|
Show InChI InChI=1S/C30H30F7N5O4/c31-18-3-1-16(2-4-18)26(17-7-19(32)9-20(33)8-17)27(38)28(43)42-25-12-39-11-24(34)23(25)6-5-22-10-40-21(13-45-22)14-46-29(44)41-15-30(35,36)37/h1-4,7-9,11-12,21-22,26-27,40H,5-6,10,13-15,38H2,(H,41,44)(H,42,43)/t21-,22+,26-,27-/m0/s1
PDB

UniProtKB/TrEMBL

B.MOAD
GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem
Article
PubMed
n/an/a 2.40n/an/an/an/an/an/a



Merck Research Laboratories

Curated by ChEMBL


Assay Description
Inhibition of wild-type HIV1 protease expressed in Escherichia coli assessed as reduction in product formation preincubated for 30 mins followed by a...


ACS Med Chem Lett 7: 702-7 (2016)


Article DOI: 10.1021/acsmedchemlett.6b00135
BindingDB Entry DOI: 10.7270/Q28W3G74
More data for this
Ligand-Target Pair
Protease


(Human immunodeficiency virus 1 (HIV-1))
BDBM50190625
PNG
(CHEMBL3828552)
Show SMILES N[C@@H]([C@@H](c1ccc(F)cc1)c1cccc(F)c1)C(=O)Nc1cncc(F)c1CC[C@@H]1CN[C@H](COC(=O)NCC(F)(F)F)CO1 |r|
Show InChI InChI=1S/C30H31F6N5O4/c31-19-6-4-17(5-7-19)26(18-2-1-3-20(32)10-18)27(37)28(42)41-25-13-38-12-24(33)23(25)9-8-22-11-39-21(14-44-22)15-45-29(43)40-16-30(34,35)36/h1-7,10,12-13,21-22,26-27,39H,8-9,11,14-16,37H2,(H,40,43)(H,41,42)/t21-,22+,26-,27-/m0/s1
PDB

UniProtKB/TrEMBL

B.MOAD
GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem
Article
PubMed
n/an/a 2.40n/an/an/an/an/an/a



Merck Research Laboratories

Curated by ChEMBL


Assay Description
Inhibition of wild-type HIV1 protease expressed in Escherichia coli assessed as reduction in product formation preincubated for 30 mins followed by a...


ACS Med Chem Lett 7: 702-7 (2016)


Article DOI: 10.1021/acsmedchemlett.6b00135
BindingDB Entry DOI: 10.7270/Q28W3G74
More data for this
Ligand-Target Pair
Protease


(Human immunodeficiency virus 1 (HIV-1))
BDBM50190638
PNG
(CHEMBL3828119)
Show SMILES COC(=O)N[C@@H](C(c1ccccc1)c1ccccc1)C(=O)Nc1ccccc1CC[C@@H]1CN[C@H](COC(=O)NCc2ccc(Cl)s2)CO1 |r|
Show InChI InChI=1S/C36H39ClN4O6S/c1-45-36(44)41-33(32(25-11-4-2-5-12-25)26-13-6-3-7-14-26)34(42)40-30-15-9-8-10-24(30)16-17-28-20-38-27(22-46-28)23-47-35(43)39-21-29-18-19-31(37)48-29/h2-15,18-19,27-28,32-33,38H,16-17,20-23H2,1H3,(H,39,43)(H,40,42)(H,41,44)/t27-,28+,33-/m0/s1
PDB

UniProtKB/TrEMBL

B.MOAD
GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem

Similars

Article
PubMed
n/an/a 2.40n/an/an/an/an/an/a



Merck Research Laboratories

Curated by ChEMBL


Assay Description
Inhibition of wild-type HIV1 protease expressed in Escherichia coli assessed as reduction in product formation preincubated for 30 mins followed by a...


ACS Med Chem Lett 7: 702-7 (2016)


Article DOI: 10.1021/acsmedchemlett.6b00135
BindingDB Entry DOI: 10.7270/Q28W3G74
More data for this
Ligand-Target Pair
Protease


(Human immunodeficiency virus 1 (HIV-1))
BDBM50190631
PNG
(CHEMBL3828166)
Show SMILES N[C@@H](C(c1ccccc1)c1ccccc1)C(=O)Nc1cccc(F)c1CC[C@@H]1CN[C@H](COC(=O)NCC(F)(F)F)CO1 |r|
Show InChI InChI=1S/C31H34F4N4O4/c32-25-12-7-13-26(39-29(40)28(36)27(20-8-3-1-4-9-20)21-10-5-2-6-11-21)24(25)15-14-23-16-37-22(17-42-23)18-43-30(41)38-19-31(33,34)35/h1-13,22-23,27-28,37H,14-19,36H2,(H,38,41)(H,39,40)/t22-,23+,28-/m0/s1
PDB

UniProtKB/TrEMBL

B.MOAD
GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem

Similars

Article
PubMed
n/an/a 3.10n/an/an/an/an/an/a



Merck Research Laboratories

Curated by ChEMBL


Assay Description
Inhibition of wild-type HIV1 protease expressed in Escherichia coli assessed as reduction in product formation preincubated for 30 mins followed by a...


ACS Med Chem Lett 7: 702-7 (2016)


Article DOI: 10.1021/acsmedchemlett.6b00135
BindingDB Entry DOI: 10.7270/Q28W3G74
More data for this
Ligand-Target Pair
Protease


(Human immunodeficiency virus 1 (HIV-1))
BDBM50190639
PNG
(CHEMBL3827524)
Show SMILES COC(=O)N[C@@H](C(c1ccccc1)c1ccccc1)C(=O)Nc1ccccc1CC[C@@H]1CN[C@H](COC(=O)NCc2cccc(Cl)n2)CO1 |r|
Show InChI InChI=1S/C37H40ClN5O6/c1-47-37(46)43-34(33(26-12-4-2-5-13-26)27-14-6-3-7-15-27)35(44)42-31-17-9-8-11-25(31)19-20-30-22-39-29(23-48-30)24-49-36(45)40-21-28-16-10-18-32(38)41-28/h2-18,29-30,33-34,39H,19-24H2,1H3,(H,40,45)(H,42,44)(H,43,46)/t29-,30+,34-/m0/s1
PDB

UniProtKB/TrEMBL

B.MOAD
GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem

Similars

Article
PubMed
n/an/a 3.40n/an/an/an/an/an/a



Merck Research Laboratories

Curated by ChEMBL


Assay Description
Inhibition of wild-type HIV1 protease expressed in Escherichia coli assessed as reduction in product formation preincubated for 30 mins followed by a...


ACS Med Chem Lett 7: 702-7 (2016)


Article DOI: 10.1021/acsmedchemlett.6b00135
BindingDB Entry DOI: 10.7270/Q28W3G74
More data for this
Ligand-Target Pair
Protease


(Human immunodeficiency virus 1 (HIV-1))
BDBM50190629
PNG
(CHEMBL3828678)
Show SMILES COC(=O)N[C@@H](C(c1ccccc1)c1ccccc1)C(=O)Nc1cncc(F)c1CC[C@@H]1CN[C@H](COC(=O)NCC(F)(F)F)CO1 |r|
Show InChI InChI=1S/C32H35F4N5O6/c1-45-31(44)41-28(27(20-8-4-2-5-9-20)21-10-6-3-7-11-21)29(42)40-26-16-37-15-25(33)24(26)13-12-23-14-38-22(17-46-23)18-47-30(43)39-19-32(34,35)36/h2-11,15-16,22-23,27-28,38H,12-14,17-19H2,1H3,(H,39,43)(H,40,42)(H,41,44)/t22-,23+,28-/m0/s1
PDB

UniProtKB/TrEMBL

B.MOAD
GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem

Similars

Article
PubMed
n/an/a 3.5n/an/an/an/an/an/a



Merck Research Laboratories

Curated by ChEMBL


Assay Description
Inhibition of wild-type HIV1 protease expressed in Escherichia coli assessed as reduction in product formation preincubated for 30 mins followed by a...


ACS Med Chem Lett 7: 702-7 (2016)


Article DOI: 10.1021/acsmedchemlett.6b00135
BindingDB Entry DOI: 10.7270/Q28W3G74
More data for this
Ligand-Target Pair
Protease


(Human immunodeficiency virus 1 (HIV-1))
BDBM50190636
PNG
(CHEMBL3828275)
Show SMILES COC(=O)N[C@@H](C(c1ccccc1)c1ccccc1)C(=O)Nc1ccccc1CC[C@@H]1CN[C@H](COC(=O)N[C@H]2CCc3ccccc23)CO1 |r|
Show InChI InChI=1S/C40H44N4O6/c1-48-39(46)44-37(36(29-14-4-2-5-15-29)30-16-6-3-7-17-30)38(45)42-34-19-11-9-13-28(34)20-22-32-24-41-31(25-49-32)26-50-40(47)43-35-23-21-27-12-8-10-18-33(27)35/h2-19,31-32,35-37,41H,20-26H2,1H3,(H,42,45)(H,43,47)(H,44,46)/t31-,32+,35-,37-/m0/s1
PDB

UniProtKB/TrEMBL

B.MOAD
GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem

Similars

Article
PubMed
n/an/a 3.5n/an/an/an/an/an/a



Merck Research Laboratories

Curated by ChEMBL


Assay Description
Inhibition of wild-type HIV1 protease expressed in Escherichia coli assessed as reduction in product formation preincubated for 30 mins followed by a...


ACS Med Chem Lett 7: 702-7 (2016)


Article DOI: 10.1021/acsmedchemlett.6b00135
BindingDB Entry DOI: 10.7270/Q28W3G74
More data for this
Ligand-Target Pair
Protease


(Human immunodeficiency virus 1 (HIV-1))
BDBM50190641
PNG
(CHEMBL3827205)
Show SMILES COC(=O)N[C@@H](C(c1ccccc1)c1ccccc1)C(=O)Nc1ccccc1CC[C@@H]1CN[C@H](COC(=O)NCc2ccccc2F)CO1 |r|
Show InChI InChI=1S/C38H41FN4O6/c1-47-38(46)43-35(34(27-13-4-2-5-14-27)28-15-6-3-7-16-28)36(44)42-33-19-11-9-12-26(33)20-21-31-23-40-30(24-48-31)25-49-37(45)41-22-29-17-8-10-18-32(29)39/h2-19,30-31,34-35,40H,20-25H2,1H3,(H,41,45)(H,42,44)(H,43,46)/t30-,31+,35-/m0/s1
PDB

UniProtKB/TrEMBL

B.MOAD
GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem

Similars

Article
PubMed
n/an/a 3.60n/an/an/an/an/an/a



Merck Research Laboratories

Curated by ChEMBL


Assay Description
Inhibition of wild-type HIV1 protease expressed in Escherichia coli assessed as reduction in product formation preincubated for 30 mins followed by a...


ACS Med Chem Lett 7: 702-7 (2016)


Article DOI: 10.1021/acsmedchemlett.6b00135
BindingDB Entry DOI: 10.7270/Q28W3G74
More data for this
Ligand-Target Pair
Protease


(Human immunodeficiency virus 1 (HIV-1))
BDBM50190640
PNG
(CHEMBL3828355)
Show SMILES COC(=O)N[C@@H](C(c1ccccc1)c1ccccc1)C(=O)Nc1ccccc1CC[C@@H]1CN[C@H](COC(=O)NCc2ccc(F)cc2)CO1 |r|
Show InChI InChI=1S/C38H41FN4O6/c1-47-38(46)43-35(34(28-11-4-2-5-12-28)29-13-6-3-7-14-29)36(44)42-33-15-9-8-10-27(33)18-21-32-23-40-31(24-48-32)25-49-37(45)41-22-26-16-19-30(39)20-17-26/h2-17,19-20,31-32,34-35,40H,18,21-25H2,1H3,(H,41,45)(H,42,44)(H,43,46)/t31-,32+,35-/m0/s1
PDB

UniProtKB/TrEMBL

B.MOAD
GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem
Article
PubMed
n/an/a 4.10n/an/an/an/an/an/a



Merck Research Laboratories

Curated by ChEMBL


Assay Description
Inhibition of wild-type HIV1 protease expressed in Escherichia coli assessed as reduction in product formation preincubated for 30 mins followed by a...


ACS Med Chem Lett 7: 702-7 (2016)


Article DOI: 10.1021/acsmedchemlett.6b00135
BindingDB Entry DOI: 10.7270/Q28W3G74
More data for this
Ligand-Target Pair
Protease


(Human immunodeficiency virus 1 (HIV-1))
BDBM50190642
PNG
(CHEMBL3827353)
Show SMILES COC(=O)N[C@@H](C(c1ccccc1)c1ccccc1)C(=O)Nc1ccccc1CC[C@@H]1CN[C@H](COC(=O)NCc2ccccc2)CO1 |r|
Show InChI InChI=1S/C38H42N4O6/c1-46-38(45)42-35(34(29-16-7-3-8-17-29)30-18-9-4-10-19-30)36(43)41-33-20-12-11-15-28(33)21-22-32-24-39-31(25-47-32)26-48-37(44)40-23-27-13-5-2-6-14-27/h2-20,31-32,34-35,39H,21-26H2,1H3,(H,40,44)(H,41,43)(H,42,45)/t31-,32+,35-/m0/s1
PDB

UniProtKB/TrEMBL

B.MOAD
GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
PDB
UniChem

Similars

Article
PubMed
n/an/a 6.10n/an/an/an/an/an/a



Merck Research Laboratories

Curated by ChEMBL


Assay Description
Inhibition of wild-type HIV1 protease expressed in Escherichia coli assessed as reduction in product formation preincubated for 30 mins followed by a...


ACS Med Chem Lett 7: 702-7 (2016)


Article DOI: 10.1021/acsmedchemlett.6b00135
BindingDB Entry DOI: 10.7270/Q28W3G74
More data for this
Ligand-Target Pair
Protease


(Human immunodeficiency virus 1 (HIV-1))
BDBM50190627
PNG
(CHEMBL3827958)
Show SMILES N[C@@H]([C@@H](c1ccc(F)cc1)c1cccc(F)c1)C(=O)Nc1cccc(F)c1CC[C@@H]1CN[C@H](COC(=O)NCC(F)(F)F)CO1 |r|
Show InChI InChI=1S/C31H32F6N4O4/c32-20-9-7-18(8-10-20)27(19-3-1-4-21(33)13-19)28(38)29(42)41-26-6-2-5-25(34)24(26)12-11-23-14-39-22(15-44-23)16-45-30(43)40-17-31(35,36)37/h1-10,13,22-23,27-28,39H,11-12,14-17,38H2,(H,40,43)(H,41,42)/t22-,23+,27-,28-/m0/s1
PDB

UniProtKB/TrEMBL

B.MOAD
GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem

Similars

Article
PubMed
n/an/a 6.40n/an/an/an/an/an/a



Merck Research Laboratories

Curated by ChEMBL


Assay Description
Inhibition of wild-type HIV1 protease expressed in Escherichia coli assessed as reduction in product formation preincubated for 30 mins followed by a...


ACS Med Chem Lett 7: 702-7 (2016)


Article DOI: 10.1021/acsmedchemlett.6b00135
BindingDB Entry DOI: 10.7270/Q28W3G74
More data for this
Ligand-Target Pair
Protease


(Human immunodeficiency virus 1 (HIV-1))
BDBM50190626
PNG
(CHEMBL3827319)
Show SMILES N[C@@H]([C@@H](c1ccc(F)cc1)c1cc(F)cc(F)c1)C(=O)Nc1cccc(F)c1CC[C@@H]1CN[C@H](COC(=O)NCC(F)(F)F)CO1 |r|
Show InChI InChI=1S/C31H31F7N4O4/c32-19-6-4-17(5-7-19)27(18-10-20(33)12-21(34)11-18)28(39)29(43)42-26-3-1-2-25(35)24(26)9-8-23-13-40-22(14-45-23)15-46-30(44)41-16-31(36,37)38/h1-7,10-12,22-23,27-28,40H,8-9,13-16,39H2,(H,41,44)(H,42,43)/t22-,23+,27-,28-/m0/s1
PDB

UniProtKB/TrEMBL

B.MOAD
GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem
Article
PubMed
n/an/a 8.20n/an/an/an/an/an/a



Merck Research Laboratories

Curated by ChEMBL


Assay Description
Inhibition of wild-type HIV1 protease expressed in Escherichia coli assessed as reduction in product formation preincubated for 30 mins followed by a...


ACS Med Chem Lett 7: 702-7 (2016)


Article DOI: 10.1021/acsmedchemlett.6b00135
BindingDB Entry DOI: 10.7270/Q28W3G74
More data for this
Ligand-Target Pair
Protease


(Human immunodeficiency virus 1 (HIV-1))
BDBM50190637
PNG
(CHEMBL3827348)
Show SMILES COC(=O)N[C@@H](C(c1ccccc1)c1ccccc1)C(=O)Nc1ccccc1CC[C@@H]1CN[C@H](COC(=O)N[C@@H]2CCc3ccccc23)CO1 |r|
Show InChI InChI=1S/C40H44N4O6/c1-48-39(46)44-37(36(29-14-4-2-5-15-29)30-16-6-3-7-17-30)38(45)42-34-19-11-9-13-28(34)20-22-32-24-41-31(25-49-32)26-50-40(47)43-35-23-21-27-12-8-10-18-33(27)35/h2-19,31-32,35-37,41H,20-26H2,1H3,(H,42,45)(H,43,47)(H,44,46)/t31-,32+,35+,37-/m0/s1
PDB

UniProtKB/TrEMBL

B.MOAD
GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem

Similars

Article
PubMed
n/an/a 9.70n/an/an/an/an/an/a



Merck Research Laboratories

Curated by ChEMBL


Assay Description
Inhibition of wild-type HIV1 protease expressed in Escherichia coli assessed as reduction in product formation preincubated for 30 mins followed by a...


ACS Med Chem Lett 7: 702-7 (2016)


Article DOI: 10.1021/acsmedchemlett.6b00135
BindingDB Entry DOI: 10.7270/Q28W3G74
More data for this
Ligand-Target Pair
Protease


(Human immunodeficiency virus 1 (HIV-1))
BDBM50190628
PNG
(CHEMBL3827975)
Show SMILES N[C@@H](C(c1ccccc1)c1ccccc1)C(=O)Nc1cncc(F)c1CC[C@@H]1CN[C@H](COC(=O)NCC(F)(F)F)CO1 |r|
Show InChI InChI=1S/C30H33F4N5O4/c31-24-14-36-15-25(39-28(40)27(35)26(19-7-3-1-4-8-19)20-9-5-2-6-10-20)23(24)12-11-22-13-37-21(16-42-22)17-43-29(41)38-18-30(32,33)34/h1-10,14-15,21-22,26-27,37H,11-13,16-18,35H2,(H,38,41)(H,39,40)/t21-,22+,27-/m0/s1
PDB

UniProtKB/TrEMBL

B.MOAD
GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem

Similars

Article
PubMed
n/an/a 9.90n/an/an/an/an/an/a



Merck Research Laboratories

Curated by ChEMBL


Assay Description
Inhibition of wild-type HIV1 protease expressed in Escherichia coli assessed as reduction in product formation preincubated for 30 mins followed by a...


ACS Med Chem Lett 7: 702-7 (2016)


Article DOI: 10.1021/acsmedchemlett.6b00135
BindingDB Entry DOI: 10.7270/Q28W3G74
More data for this
Ligand-Target Pair
Protease


(Human immunodeficiency virus 1 (HIV-1))
BDBM50190632
PNG
(CHEMBL3827450)
Show SMILES COC(=O)N[C@@H](C(c1ccccc1)c1ccccc1)C(=O)Nc1cccc(F)c1CC[C@@H]1CN[C@H](COC(=O)NCC(F)(F)F)CO1 |r|
Show InChI InChI=1S/C33H36F4N4O6/c1-45-32(44)41-29(28(21-9-4-2-5-10-21)22-11-6-3-7-12-22)30(42)40-27-14-8-13-26(34)25(27)16-15-24-17-38-23(18-46-24)19-47-31(43)39-20-33(35,36)37/h2-14,23-24,28-29,38H,15-20H2,1H3,(H,39,43)(H,40,42)(H,41,44)/t23-,24+,29-/m0/s1
PDB

UniProtKB/TrEMBL

B.MOAD
GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem

Similars

Article
PubMed
n/an/a 12n/an/an/an/an/an/a



Merck Research Laboratories

Curated by ChEMBL


Assay Description
Inhibition of wild-type HIV1 protease expressed in Escherichia coli assessed as reduction in product formation preincubated for 30 mins followed by a...


ACS Med Chem Lett 7: 702-7 (2016)


Article DOI: 10.1021/acsmedchemlett.6b00135
BindingDB Entry DOI: 10.7270/Q28W3G74
More data for this
Ligand-Target Pair
Protease


(Human immunodeficiency virus 1 (HIV-1))
BDBM50190630
PNG
(CHEMBL3827960)
Show SMILES COC(=O)N[C@@H](C(c1ccccc1)c1ccccc1)C(=O)Nc1cnccc1CC[C@@H]1CN[C@H](COC(=O)NCC(F)(F)F)CO1 |r|
Show InChI InChI=1S/C32H36F3N5O6/c1-44-31(43)40-28(27(22-8-4-2-5-9-22)23-10-6-3-7-11-23)29(41)39-26-17-36-15-14-21(26)12-13-25-16-37-24(18-45-25)19-46-30(42)38-20-32(33,34)35/h2-11,14-15,17,24-25,27-28,37H,12-13,16,18-20H2,1H3,(H,38,42)(H,39,41)(H,40,43)/t24-,25+,28-/m0/s1
PDB

UniProtKB/TrEMBL

B.MOAD
GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem

Similars

Article
PubMed
n/an/a 14n/an/an/an/an/an/a



Merck Research Laboratories

Curated by ChEMBL


Assay Description
Inhibition of wild-type HIV1 protease expressed in Escherichia coli assessed as reduction in product formation preincubated for 30 mins followed by a...


ACS Med Chem Lett 7: 702-7 (2016)


Article DOI: 10.1021/acsmedchemlett.6b00135
BindingDB Entry DOI: 10.7270/Q28W3G74
More data for this
Ligand-Target Pair
Protease


(Human immunodeficiency virus 1 (HIV-1))
BDBM50190633
PNG
(CHEMBL3827407)
Show SMILES COC(=O)N[C@@H](C(c1ccccc1)c1ccccc1)C(=O)Nc1ccccc1CC[C@@H]1CN[C@H](COC(N)=O)CO1 |r|
Show InChI InChI=1S/C31H36N4O6/c1-39-31(38)35-28(27(22-11-4-2-5-12-22)23-13-6-3-7-14-23)29(36)34-26-15-9-8-10-21(26)16-17-25-18-33-24(19-40-25)20-41-30(32)37/h2-15,24-25,27-28,33H,16-20H2,1H3,(H2,32,37)(H,34,36)(H,35,38)/t24-,25+,28-/m0/s1
PDB

UniProtKB/TrEMBL

B.MOAD
GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem
Article
PubMed
n/an/a 20n/an/an/an/an/an/a



Merck Research Laboratories

Curated by ChEMBL


Assay Description
Inhibition of wild-type HIV1 protease expressed in Escherichia coli assessed as reduction in product formation preincubated for 30 mins followed by a...


ACS Med Chem Lett 7: 702-7 (2016)


Article DOI: 10.1021/acsmedchemlett.6b00135
BindingDB Entry DOI: 10.7270/Q28W3G74
More data for this
Ligand-Target Pair
Protease


(Human immunodeficiency virus 1 (HIV-1))
BDBM50190634
PNG
(CHEMBL3828494)
Show SMILES COC(=O)N[C@@H](C(c1ccccc1)c1ccccc1)C(=O)Nc1ccccc1CC[C@@H]1CN[C@H](COC(=O)NCC(F)(F)F)CO1 |r|
Show InChI InChI=1S/C33H37F3N4O6/c1-44-32(43)40-29(28(23-11-4-2-5-12-23)24-13-6-3-7-14-24)30(41)39-27-15-9-8-10-22(27)16-17-26-18-37-25(19-45-26)20-46-31(42)38-21-33(34,35)36/h2-15,25-26,28-29,37H,16-21H2,1H3,(H,38,42)(H,39,41)(H,40,43)/t25-,26+,29-/m0/s1
PDB

UniProtKB/TrEMBL

B.MOAD
GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem

Similars

Article
PubMed
n/an/a 27n/an/an/an/an/an/a



Merck Research Laboratories

Curated by ChEMBL


Assay Description
Inhibition of wild-type HIV1 protease expressed in Escherichia coli assessed as reduction in product formation preincubated for 30 mins followed by a...


ACS Med Chem Lett 7: 702-7 (2016)


Article DOI: 10.1021/acsmedchemlett.6b00135
BindingDB Entry DOI: 10.7270/Q28W3G74
More data for this
Ligand-Target Pair
Protease


(Human immunodeficiency virus 1 (HIV-1))
BDBM50190635
PNG
(CHEMBL3827668)
Show SMILES COC(=O)N[C@@H](C(c1ccccc1)c1ccccc1)C(=O)Nc1ccccc1CC[C@@H]1CN[C@H](COC(=O)NC(C)C)CO1 |r|
Show InChI InChI=1S/C34H42N4O6/c1-23(2)36-34(41)44-22-27-21-43-28(20-35-27)19-18-24-12-10-11-17-29(24)37-32(39)31(38-33(40)42-3)30(25-13-6-4-7-14-25)26-15-8-5-9-16-26/h4-17,23,27-28,30-31,35H,18-22H2,1-3H3,(H,36,41)(H,37,39)(H,38,40)/t27-,28+,31-/m0/s1
PDB

UniProtKB/TrEMBL

B.MOAD
GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem

Similars

Article
PubMed
n/an/a 37n/an/an/an/an/an/a



Merck Research Laboratories

Curated by ChEMBL


Assay Description
Inhibition of wild-type HIV1 protease expressed in Escherichia coli assessed as reduction in product formation preincubated for 30 mins followed by a...


ACS Med Chem Lett 7: 702-7 (2016)


Article DOI: 10.1021/acsmedchemlett.6b00135
BindingDB Entry DOI: 10.7270/Q28W3G74
More data for this
Ligand-Target Pair
Cytochrome P450 2C8


(Homo sapiens (Human))
BDBM50444436
PNG
(CHEMBL3092124)
Show SMILES Cc1cc2c(c(C(O)=O)n(Cc3cc4ccccc4nc3Cl)c2cc1F)-c1ccc[nH]c1=O |(42.83,-22,;44.16,-22.77,;45.49,-22,;46.83,-22.76,;48.3,-22.27,;49.22,-23.52,;50.76,-23.51,;51.52,-22.17,;51.54,-24.84,;48.31,-24.78,;49.09,-26.11,;48.34,-27.45,;46.8,-27.46,;46.05,-28.8,;44.51,-28.81,;43.75,-30.15,;44.54,-31.48,;46.07,-31.46,;46.82,-30.12,;48.37,-30.11,;49.12,-28.77,;50.66,-28.74,;46.83,-24.31,;45.49,-25.08,;44.16,-24.31,;42.82,-25.08,;48.3,-20.74,;46.98,-19.97,;46.97,-18.43,;48.31,-17.66,;49.65,-18.44,;49.64,-19.97,;50.97,-20.75,)|
Show InChI InChI=1S/C25H17ClFN3O3/c1-13-9-17-20(11-18(13)27)30(12-15-10-14-5-2-3-7-19(14)29-23(15)26)22(25(32)33)21(17)16-6-4-8-28-24(16)31/h2-11H,12H2,1H3,(H,28,31)(H,32,33)
PDB

KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
PDB
UniChem
Article
PubMed
n/an/a 2.10E+4n/an/an/an/an/an/a



Merck Research Laboratories

Curated by ChEMBL


Assay Description
Inhibition of CYP2C8 in human liver microsomes measured after concurrent incubation


Bioorg Med Chem Lett 23: 6585-7 (2013)


Article DOI: 10.1016/j.bmcl.2013.10.060
BindingDB Entry DOI: 10.7270/Q2GF0W06
More data for this
Ligand-Target Pair
Cytochrome P450 2C8


(Homo sapiens (Human))
BDBM50444436
PNG
(CHEMBL3092124)
Show SMILES Cc1cc2c(c(C(O)=O)n(Cc3cc4ccccc4nc3Cl)c2cc1F)-c1ccc[nH]c1=O |(42.83,-22,;44.16,-22.77,;45.49,-22,;46.83,-22.76,;48.3,-22.27,;49.22,-23.52,;50.76,-23.51,;51.52,-22.17,;51.54,-24.84,;48.31,-24.78,;49.09,-26.11,;48.34,-27.45,;46.8,-27.46,;46.05,-28.8,;44.51,-28.81,;43.75,-30.15,;44.54,-31.48,;46.07,-31.46,;46.82,-30.12,;48.37,-30.11,;49.12,-28.77,;50.66,-28.74,;46.83,-24.31,;45.49,-25.08,;44.16,-24.31,;42.82,-25.08,;48.3,-20.74,;46.98,-19.97,;46.97,-18.43,;48.31,-17.66,;49.65,-18.44,;49.64,-19.97,;50.97,-20.75,)|
Show InChI InChI=1S/C25H17ClFN3O3/c1-13-9-17-20(11-18(13)27)30(12-15-10-14-5-2-3-7-19(14)29-23(15)26)22(25(32)33)21(17)16-6-4-8-28-24(16)31/h2-11H,12H2,1H3,(H,28,31)(H,32,33)
PDB

KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
PDB
UniChem
Article
PubMed
n/an/a 3.00E+4n/an/an/an/an/an/a



Merck Research Laboratories

Curated by ChEMBL


Assay Description
Inhibition of CYP2C8 in human liver microsomes measured after compound pre-incubation


Bioorg Med Chem Lett 23: 6585-7 (2013)


Article DOI: 10.1016/j.bmcl.2013.10.060
BindingDB Entry DOI: 10.7270/Q2GF0W06
More data for this
Ligand-Target Pair
Cytochrome P450 2C19


(Homo sapiens (Human))
BDBM50444436
PNG
(CHEMBL3092124)
Show SMILES Cc1cc2c(c(C(O)=O)n(Cc3cc4ccccc4nc3Cl)c2cc1F)-c1ccc[nH]c1=O |(42.83,-22,;44.16,-22.77,;45.49,-22,;46.83,-22.76,;48.3,-22.27,;49.22,-23.52,;50.76,-23.51,;51.52,-22.17,;51.54,-24.84,;48.31,-24.78,;49.09,-26.11,;48.34,-27.45,;46.8,-27.46,;46.05,-28.8,;44.51,-28.81,;43.75,-30.15,;44.54,-31.48,;46.07,-31.46,;46.82,-30.12,;48.37,-30.11,;49.12,-28.77,;50.66,-28.74,;46.83,-24.31,;45.49,-25.08,;44.16,-24.31,;42.82,-25.08,;48.3,-20.74,;46.98,-19.97,;46.97,-18.43,;48.31,-17.66,;49.65,-18.44,;49.64,-19.97,;50.97,-20.75,)|
Show InChI InChI=1S/C25H17ClFN3O3/c1-13-9-17-20(11-18(13)27)30(12-15-10-14-5-2-3-7-19(14)29-23(15)26)22(25(32)33)21(17)16-6-4-8-28-24(16)31/h2-11H,12H2,1H3,(H,28,31)(H,32,33)
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
PDB
UniChem
Article
PubMed
n/an/a>5.00E+4n/an/an/an/an/an/a



Merck Research Laboratories

Curated by ChEMBL


Assay Description
Inhibition of CYP2CJ in human liver microsomes measured after compound pre-incubation


Bioorg Med Chem Lett 23: 6585-7 (2013)


Article DOI: 10.1016/j.bmcl.2013.10.060
BindingDB Entry DOI: 10.7270/Q2GF0W06
More data for this
Ligand-Target Pair
Cytochrome P450 2C9


(Homo sapiens (Human))
BDBM50444436
PNG
(CHEMBL3092124)
Show SMILES Cc1cc2c(c(C(O)=O)n(Cc3cc4ccccc4nc3Cl)c2cc1F)-c1ccc[nH]c1=O |(42.83,-22,;44.16,-22.77,;45.49,-22,;46.83,-22.76,;48.3,-22.27,;49.22,-23.52,;50.76,-23.51,;51.52,-22.17,;51.54,-24.84,;48.31,-24.78,;49.09,-26.11,;48.34,-27.45,;46.8,-27.46,;46.05,-28.8,;44.51,-28.81,;43.75,-30.15,;44.54,-31.48,;46.07,-31.46,;46.82,-30.12,;48.37,-30.11,;49.12,-28.77,;50.66,-28.74,;46.83,-24.31,;45.49,-25.08,;44.16,-24.31,;42.82,-25.08,;48.3,-20.74,;46.98,-19.97,;46.97,-18.43,;48.31,-17.66,;49.65,-18.44,;49.64,-19.97,;50.97,-20.75,)|
Show InChI InChI=1S/C25H17ClFN3O3/c1-13-9-17-20(11-18(13)27)30(12-15-10-14-5-2-3-7-19(14)29-23(15)26)22(25(32)33)21(17)16-6-4-8-28-24(16)31/h2-11H,12H2,1H3,(H,28,31)(H,32,33)
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
PDB
UniChem
Article
PubMed
n/an/a>5.00E+4n/an/an/an/an/an/a



Merck Research Laboratories

Curated by ChEMBL


Assay Description
Inhibition of CYP2C9 in human liver microsomes measured after compound pre-incubation


Bioorg Med Chem Lett 23: 6585-7 (2013)


Article DOI: 10.1016/j.bmcl.2013.10.060
BindingDB Entry DOI: 10.7270/Q2GF0W06
More data for this
Ligand-Target Pair
Cytochrome P450 1A2


(Homo sapiens (Human))
BDBM50444436
PNG
(CHEMBL3092124)
Show SMILES Cc1cc2c(c(C(O)=O)n(Cc3cc4ccccc4nc3Cl)c2cc1F)-c1ccc[nH]c1=O |(42.83,-22,;44.16,-22.77,;45.49,-22,;46.83,-22.76,;48.3,-22.27,;49.22,-23.52,;50.76,-23.51,;51.52,-22.17,;51.54,-24.84,;48.31,-24.78,;49.09,-26.11,;48.34,-27.45,;46.8,-27.46,;46.05,-28.8,;44.51,-28.81,;43.75,-30.15,;44.54,-31.48,;46.07,-31.46,;46.82,-30.12,;48.37,-30.11,;49.12,-28.77,;50.66,-28.74,;46.83,-24.31,;45.49,-25.08,;44.16,-24.31,;42.82,-25.08,;48.3,-20.74,;46.98,-19.97,;46.97,-18.43,;48.31,-17.66,;49.65,-18.44,;49.64,-19.97,;50.97,-20.75,)|
Show InChI InChI=1S/C25H17ClFN3O3/c1-13-9-17-20(11-18(13)27)30(12-15-10-14-5-2-3-7-19(14)29-23(15)26)22(25(32)33)21(17)16-6-4-8-28-24(16)31/h2-11H,12H2,1H3,(H,28,31)(H,32,33)
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
PDB
UniChem
Article
PubMed
n/an/a>5.00E+4n/an/an/an/an/an/a



Merck Research Laboratories

Curated by ChEMBL


Assay Description
Inhibition of CYP1A2 in human liver microsomes measured after compound pre-incubation


Bioorg Med Chem Lett 23: 6585-7 (2013)


Article DOI: 10.1016/j.bmcl.2013.10.060
BindingDB Entry DOI: 10.7270/Q2GF0W06
More data for this
Ligand-Target Pair
Cytochrome P450 2D6


(Homo sapiens (Human))
BDBM50444436
PNG
(CHEMBL3092124)
Show SMILES Cc1cc2c(c(C(O)=O)n(Cc3cc4ccccc4nc3Cl)c2cc1F)-c1ccc[nH]c1=O |(42.83,-22,;44.16,-22.77,;45.49,-22,;46.83,-22.76,;48.3,-22.27,;49.22,-23.52,;50.76,-23.51,;51.52,-22.17,;51.54,-24.84,;48.31,-24.78,;49.09,-26.11,;48.34,-27.45,;46.8,-27.46,;46.05,-28.8,;44.51,-28.81,;43.75,-30.15,;44.54,-31.48,;46.07,-31.46,;46.82,-30.12,;48.37,-30.11,;49.12,-28.77,;50.66,-28.74,;46.83,-24.31,;45.49,-25.08,;44.16,-24.31,;42.82,-25.08,;48.3,-20.74,;46.98,-19.97,;46.97,-18.43,;48.31,-17.66,;49.65,-18.44,;49.64,-19.97,;50.97,-20.75,)|
Show InChI InChI=1S/C25H17ClFN3O3/c1-13-9-17-20(11-18(13)27)30(12-15-10-14-5-2-3-7-19(14)29-23(15)26)22(25(32)33)21(17)16-6-4-8-28-24(16)31/h2-11H,12H2,1H3,(H,28,31)(H,32,33)
PDB

UniProtKB/SwissProt

GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
PDB
UniChem
Article
PubMed
n/an/a>5.00E+4n/an/an/an/an/an/a



Merck Research Laboratories

Curated by ChEMBL


Assay Description
Inhibition of CYP2D6 in human liver microsomes measured after concurrent incubation


Bioorg Med Chem Lett 23: 6585-7 (2013)


Article DOI: 10.1016/j.bmcl.2013.10.060
BindingDB Entry DOI: 10.7270/Q2GF0W06
More data for this
Ligand-Target Pair
Cytochrome P450 2D6


(Homo sapiens (Human))
BDBM50444436
PNG
(CHEMBL3092124)
Show SMILES Cc1cc2c(c(C(O)=O)n(Cc3cc4ccccc4nc3Cl)c2cc1F)-c1ccc[nH]c1=O |(42.83,-22,;44.16,-22.77,;45.49,-22,;46.83,-22.76,;48.3,-22.27,;49.22,-23.52,;50.76,-23.51,;51.52,-22.17,;51.54,-24.84,;48.31,-24.78,;49.09,-26.11,;48.34,-27.45,;46.8,-27.46,;46.05,-28.8,;44.51,-28.81,;43.75,-30.15,;44.54,-31.48,;46.07,-31.46,;46.82,-30.12,;48.37,-30.11,;49.12,-28.77,;50.66,-28.74,;46.83,-24.31,;45.49,-25.08,;44.16,-24.31,;42.82,-25.08,;48.3,-20.74,;46.98,-19.97,;46.97,-18.43,;48.31,-17.66,;49.65,-18.44,;49.64,-19.97,;50.97,-20.75,)|
Show InChI InChI=1S/C25H17ClFN3O3/c1-13-9-17-20(11-18(13)27)30(12-15-10-14-5-2-3-7-19(14)29-23(15)26)22(25(32)33)21(17)16-6-4-8-28-24(16)31/h2-11H,12H2,1H3,(H,28,31)(H,32,33)
PDB

UniProtKB/SwissProt

GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
PDB
UniChem
Article
PubMed
n/an/a>5.00E+4n/an/an/an/an/an/a



Merck Research Laboratories

Curated by ChEMBL


Assay Description
Inhibition of CYP2D6 in human liver microsomes measured after compound pre-incubation


Bioorg Med Chem Lett 23: 6585-7 (2013)


Article DOI: 10.1016/j.bmcl.2013.10.060
BindingDB Entry DOI: 10.7270/Q2GF0W06
More data for this
Ligand-Target Pair
Cytochrome P450 2C19


(Homo sapiens (Human))
BDBM50444436
PNG
(CHEMBL3092124)
Show SMILES Cc1cc2c(c(C(O)=O)n(Cc3cc4ccccc4nc3Cl)c2cc1F)-c1ccc[nH]c1=O |(42.83,-22,;44.16,-22.77,;45.49,-22,;46.83,-22.76,;48.3,-22.27,;49.22,-23.52,;50.76,-23.51,;51.52,-22.17,;51.54,-24.84,;48.31,-24.78,;49.09,-26.11,;48.34,-27.45,;46.8,-27.46,;46.05,-28.8,;44.51,-28.81,;43.75,-30.15,;44.54,-31.48,;46.07,-31.46,;46.82,-30.12,;48.37,-30.11,;49.12,-28.77,;50.66,-28.74,;46.83,-24.31,;45.49,-25.08,;44.16,-24.31,;42.82,-25.08,;48.3,-20.74,;46.98,-19.97,;46.97,-18.43,;48.31,-17.66,;49.65,-18.44,;49.64,-19.97,;50.97,-20.75,)|
Show InChI InChI=1S/C25H17ClFN3O3/c1-13-9-17-20(11-18(13)27)30(12-15-10-14-5-2-3-7-19(14)29-23(15)26)22(25(32)33)21(17)16-6-4-8-28-24(16)31/h2-11H,12H2,1H3,(H,28,31)(H,32,33)
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
PDB
UniChem
Article
PubMed
n/an/a>5.00E+4n/an/an/an/an/an/a



Merck Research Laboratories

Curated by ChEMBL


Assay Description
Inhibition of CYP2CJ in human liver microsomes measured after concurrent incubation


Bioorg Med Chem Lett 23: 6585-7 (2013)


Article DOI: 10.1016/j.bmcl.2013.10.060
BindingDB Entry DOI: 10.7270/Q2GF0W06
More data for this
Ligand-Target Pair
Cytochrome P450 2C9


(Homo sapiens (Human))
BDBM50444436
PNG
(CHEMBL3092124)
Show SMILES Cc1cc2c(c(C(O)=O)n(Cc3cc4ccccc4nc3Cl)c2cc1F)-c1ccc[nH]c1=O |(42.83,-22,;44.16,-22.77,;45.49,-22,;46.83,-22.76,;48.3,-22.27,;49.22,-23.52,;50.76,-23.51,;51.52,-22.17,;51.54,-24.84,;48.31,-24.78,;49.09,-26.11,;48.34,-27.45,;46.8,-27.46,;46.05,-28.8,;44.51,-28.81,;43.75,-30.15,;44.54,-31.48,;46.07,-31.46,;46.82,-30.12,;48.37,-30.11,;49.12,-28.77,;50.66,-28.74,;46.83,-24.31,;45.49,-25.08,;44.16,-24.31,;42.82,-25.08,;48.3,-20.74,;46.98,-19.97,;46.97,-18.43,;48.31,-17.66,;49.65,-18.44,;49.64,-19.97,;50.97,-20.75,)|
Show InChI InChI=1S/C25H17ClFN3O3/c1-13-9-17-20(11-18(13)27)30(12-15-10-14-5-2-3-7-19(14)29-23(15)26)22(25(32)33)21(17)16-6-4-8-28-24(16)31/h2-11H,12H2,1H3,(H,28,31)(H,32,33)
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
PDB
UniChem
Article
PubMed
n/an/a>5.00E+4n/an/an/an/an/an/a



Merck Research Laboratories

Curated by ChEMBL


Assay Description
Inhibition of CYP2C9 in human liver microsomes measured after concurrent incubation


Bioorg Med Chem Lett 23: 6585-7 (2013)


Article DOI: 10.1016/j.bmcl.2013.10.060
BindingDB Entry DOI: 10.7270/Q2GF0W06
More data for this
Ligand-Target Pair
Displayed 1 to 50 (of 53 total )  |  Next  |  Last  >>
Jump to: